Menumenu
  • Home
  • Events
  • Insight into the use and indication of drugs: a pilot study in patients with colon or rectal cancer

Josine Kuiper, our oncology expert researcher, presented the first results of the Rx-pilot that provides insight into the use and outcomes of medicines in hospitals. Her presentation was held at the Dutch hospital pharmacy conference 2016. The pilot study was set-up at Jeroen Bosch Hospital and focused on the linkage of PHARMO’s in-patient pharmacy data to the Dutch Surgical Colorectal Audit (DSCA) from the Dutch Institute for Clinical Auditing (DICA). Patients who had undergone laparoscopy were compared to patients who had undergone open surgery for the treatment of colon or rectal cancer. The results of this study show that the majority of patients with colon or rectal cancer is treated using a laparoscopy. The most common used drugs during hospitalization were analgesics in both patients who had open or laparoscopy surgery, followed by anesthetics. In patients who had undergone open surgery, antibacterial medication was among the top 5 most dispensed medications during hospitalization. On the contrary, antibacterial medication was not in the top 5 most prescribed medication for patients who had a laparoscopy. Chemotherapy regimens were similar among both groups, the majority of patients received CapOx.

With this study PHARMO and DICA will help hospital pharmacist to gain more insight into the use of medications in hospitals and whether patients are treated according to the Dutch guidelines.